Abstract Background Cisplatin (DDP) resistance has long posed a challenge in the clinical treatment of lung cancer (LC). Insulin-like growth factor 2 binding protein 2 (IGF2BP2) has been identified as an oncogenic factor in LC. whereas its specific role in DDP resistance in LC remains unclear. Results In this study. https://halohealthcarers.shop/product-category/toe-separators/